Novel therapy may improve survival for patients with malignant gliomas

A novel therapy engineered by Northwestern Medicine investigators improved progression-free and overall survival for patients with newly diagnosed malignant gliomas, according to results from a recent phase I clinical trial published in The Lancet Oncology.

source https://medicalxpress.com/news/2021-07-therapy-survival-patients-malignant-gliomas.html